Advertisement

 

 

Allosteric Mechanism of Quinoline Inhibitors for HIV RT-associated RNase with MD simulation and Dynamics Fluctuation Network.

Allosteric Mechanism of Quinoline Inhibitors for HIV RT-associated RNase with MD simulation and Dynamics Fluctuation Network.
Author Information (click to view)

Cai Y, Liu H, Chen H,


Cai Y, Liu H, Chen H, (click to view)

Cai Y, Liu H, Chen H,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Chemical biology & drug design 2017 11 15() doi 10.1111/cbdd.13146

Abstract

The human immunodeficiency virus (HIV) is a retrovirus which infects T lymphocyte of human body and causes Immunodeficiency. Reverse transcriptase inhibitors (RTIs) can inhibit some functions of RT, preventing virus synthesis (double-stranded DNA), so that HIV virus replication can be reduced. Experimental results indicate a series of benzimidazole-based inhibitors which target HIV RT-associate RNase to inhibit the reverse transcription of HIV virus. However, the allosteric mechanism is still unclear. Here, molecular dynamics simulations and dynamics fluctuation network analysis were used to reveal the binding mode between the inhibitors and RT-associate RNase. The most active molecule has more hydrophobic and electrostatic interactions than the less active inhibitor. Dynamics correlation network analysis indicates that the most active inhibitor perturbs the network of RT-associate RNase and decreases the correlation of nodes. 3D-QSAR model suggests that two robust and reliable models were constructed and validated by independent test set. 3D-QSAR model also shows that bulky negatively charged or hydrophilic substituent is favourable to bioactivity. These results reveal the allosteric mechanism of quinoline inhibitors and help to improve the bioactivity. This article is protected by copyright. All rights reserved.

Submit a Comment

Your email address will not be published. Required fields are marked *

four × three =

[ HIDE/SHOW ]